specific tolerance
donor specific
specific CAR Treg
use of Treg specific
specificity of human Treg
specificity of Treg therapy
lack antigen specificity
Alloantigen-specific Regulatory T cells
Chimeric Antigen Receptor
CAR Tregs
sufficient numbers of potent donor-specific Tregs
allograft tolerance Organ transplantation
Pr Levings
Induction of donor
transplant-relevant antigen
Pr Glaichenhaus
indefinite graft survival
impact of alloantigen
kidney transplantation
return phase
outgoing phase
Prevention of rejection
terminal organ failure
Grail of transplant immunologists
team
group
Child
best life
Pharmacologie Moléculaire et Cellulaire
Family Research Institute
humoral alloimmune responses
Valbonne
clinical trial
CD4
FOXP3
technology
response of recipient’s immune system
immunosuppressive drugs
adoptive transfer of ex
France
Vancouver
treatment
development
experimental models
ability
potency
applicable strategies
global fellowship
program
Canada
morbidity
risk
lab
key data
destructive process
years
year action
researcher
limitation
tenured position
Translation
approach
main ambition
objective
infections
cancers